Garrett Wealth Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,903
Closed -$425K 152
2026
Q1
$425K Buy
4,903
+459
+10% +$44K 0.08% 84
2025
Q4
$427K Sell
4,444
-206
-4% -$20K 0.08% 79
2025
Q3
$443K Buy
4,650
+1
+0% +$92 0.09% 72
2025
Q2
$405K Buy
4,649
+2
+0% +$170 0.09% 73
2025
Q1
$418K Buy
4,647
+144
+3% +$12.9K 0.09% 68
2024
Q4
$360K Sell
4,503
-38
-0.8% -$3.29K 0.08% 72
2024
Q3
$409K Buy
4,541
+2
+0% +$168 0.1% 63
2024
Q2
$357K Buy
4,539
+139
+3% +$11.4K 0.13% 60
2024
Q1
$384K Buy
4,400
+1
+0% +$85 0.16% 45
2023
Q4
$362K Sell
4,399
-71
-2% -$5.41K 0.15% 39
2023
Q3
$350K Buy
+4,470
New +$374K 0.16% 40
2019
Q4
Sell
-204
Closed -$22.2K 406
2019
Q3
$22.2K Buy
+204
New +$21.3K 0.02% 198

Other funds holding MDT

Garrett Wealth Advisory Group's MDT Position: Q2 2026 in Review

Garrett Wealth Advisory Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,903 shares — an estimated $425K sold.

Garrett Wealth Advisory Group first reported a position in MDT in Q3 2019 and held it in 12 quarters. The position peaked at $443K in Q3 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Garrett Wealth Advisory Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 4,903 Medtronic shares in Q2 2026, an estimated $425K.
  • Garrett Wealth Advisory Group first reported a position in Medtronic in Q3 2019 and held it in 12 quarters.
  • Garrett Wealth Advisory Group's Medtronic position peaked at $443K in Q3 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Garrett Wealth Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.